1 completed, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow APOKYN: new trials by email Literature Review of APOKYN trials Research Report on APOKYN
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN® APOKYN, Physical Therapy - Parkinson's Disease, Motor Symptoms | Phase 4 | Terminated | MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals | 13 | 2016-01-01 | 2023-09-01 |
| Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) APOKYN, L-dopa, Trimethobenzamide - Parkinson's Disease, Motor Symptoms | Phase 4 | Completed | MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals | 127 | 2012-12-01 | 2023-08-14 |
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals (2)
United States (2)
Gianpiera H. Ceresoli-Borroni, PhD (1) · Mark Pirner, MD (1)